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bedrest,6 which is usually related to a coexistent spine
pathologic condition prevalent in their age groups.
Therefore, early ambulation after angiography may reduce
costs, but this remains unproved.
Percutaneous devices to close arterial access puncture
sites have the potential benefits of preventing arterial hem-
orrhage and facilitating rapid patient mobilization and dis-
charge (4.5 vs 17.8 hours to ambulation, P < .0001).7,8
The most popular technique for puncture site closure at
our institution is the percutaneous suturing device
(Perclose, Redwood City, Calif).9,10 Large randomized
trials of these devices versus manual compression have
been conducted in the United States and Europe, demon-
strating more rapid hemostasis and patient discharge with-
out increasing complication rates.9,11 However, the
infrequent vascular injuries produced by these devices can
be significantly more challenging to manage surgically
than complications encountered before their introduction.
A series of consecutive cases requiring vascular surgical
intervention form the basis of this report.
MATERIAL AND METHODS
All patients evaluated on the combined University of
Colorado and Denver Veterans Affairs Medical Center vas-
cular services from August 1997 to September 2000 have
been entered into a vascular registry database (Atrium
Software, Hudson, NH). All patients who sustained arte-
rial complications related to a percutaneous suturing
The extensive use of endovascular therapy has pro-
duced a concomitant increase in iatrogenic vascular
trauma.1-3 Intravascular stents placed in small-caliber
arteries with greater thrombotic potential have necessi-
tated improved antiplatelet therapy.4,5 Thrombolytic
therapy for acute thrombosis requires postprocedure anti-
coagulation. In ironic contrast to the move toward “min-
imally invasive” procedures, puncture sites of 8F to 10F
are commonplace.
In addition to this greater risk of arterial access injury,
angiographers attempt to contain costs while providing
more extensive services. The time and effort required for
personnel to compress arteries manually for hemostasis are
substantial, particularly because of the increased use of
more potent anticoagulant and antiplatelet therapy.
Patients often complain of the postprocedural-enforced
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Objective: The purpose of this study was to examine the patterns of injury and the strategies of surgical repair of iatro-
genic vascular injuries from a percutaneous vascular suturing device after arterial cannulation.
Methods: We retrospectively reviewed the clinical experience from an academic vascular surgical practice over a 2-year
period. The subjects were patients undergoing vascular repair of iatrogenic vascular injury after deployment of a per-
cutaneous vascular suturing device. Interventions were direct repair of arterial injury (with or without device extrac-
tion) or arterial thrombectomy and repair. The main outcome variables included patterns of arterial injury, magnitude
of arterial repair, limb salvage, hospital stay, and perioperative mortality and morbidity rates.
Results: From August 1998 through August 2000, eight patients (4 men, 4 women; median age, 55 years; range, 44-
80 years) required vascular operations for complications of percutaneous suturing devices after diagnostic (2) or ther-
apeutic (6) arteriograms through a transfemoral approach. Complications included four pseudoaneurysms (1 infected)
due to arterial tear from suture pull through, two entrapped closure devices due to device malfunction, and two arte-
rial thromboses due to narrowing/severe intimal dissection. All patients required operative intervention. Direct suture
repair with or without device removal was performed in five patients, arterial debridement with vein patch angioplasty
in one patient, and arterial thrombectomy and vein patch angioplasty in two patients. There were no perioperative
deaths. The median hospital stay was 5 days (range, 2-33). Limbs were salvaged in all patients with a mean follow-up
of 4.8 months (range, 1-13).
Conclusions: Although abbreviated postangiography recovery periods and early ambulation have motivated the wide-
spread use of percutaneous suturing devices, the infrequent occurrence of vascular injuries produced by these devices
can be significantly more challenging than simple acute pseudoaneurysms or hemorrhage. In addition, thrombotic com-
plications have a small but finite risk of limb loss. (J Vasc Surg 2001;33:943-7.)
device were analyzed from this database. Medical records
were reviewed to determine demographic information,
type (diagnostic or therapeutic) of interventional proce-
dure, and risk factors for complications (concurrent anti-
coagulation use, obesity, peripheral vascular disease, prior
ipsilateral arteriogram). In addition, the presenting symp-
toms, the arterial pathologic condition encountered (hem-
orrhage, thrombosis, retained foreign body), and the
requirement for transfusion were recorded. The anatomic
location (common femoral artery, profunda femoral
artery, or superficial femoral artery) and geometric loca-
tion (anterior, medial, or lateral) of the arterial access
puncture site were determined. Finally, the details of the
arterial reconstruction and immediate and late results were
ascertained. Results were grouped according to the arte-
rial pathologic condition encountered, which has both
unique injury patterns and device-design implications.
RESULTS
Overall device use. Percutaneous suturing devices
were introduced at the University of Colorado and Denver
Veterans Affairs Medical Center coronary angiography
and interventional radiology suites in August 1998.
Approximately 3000 percutaneous suturing devices have
been used to close percutaneous arterial angiographic
puncture sites during the subsequent 24 months. Eight
arterial complications required vascular surgical repair dur-
ing this period, for an incidence of 0.3%.
Patients. The median age of the eight patients was 55
years (range, 44-80). There were four men and four
women. Demographics of the patients are listed in the
Table. Six cases were therapeutic (≥ 6F), and two were
diagnostic (6F). No patients had associated peripheral vas-
cular disease that was based on palpable peripheral pulses
before angiography and normal postoperative ankle
brachial indices/pulses. Two patients had previous ipsilat-
eral femoral artery access procedures, 2 weeks and 3 years
earlier. The median hospital stay was 5 days (range, 2-33).
Survival and limb salvage were 100% at mean follow-up of
4.8 months (range, 1-13).
Arterial hemorrhage. Immediate arterial hemor-
rhage complicated percutaneous suture device deployment
in three patients (two Prostar and one Techstar; Perclose,
Redwood City, Calif). In each instance, the suture pulled
through the arterial wall when the extracorporeal knot was
placed. All of these patients were obese (mean weight, 92
kg). Catheter size was 6F in two cases, and 8F in the other.
All patients were receiving clopidogrel at the time of the
procedure, and one patient was also receiving intravenous
heparin.
All acute hematomas were large (≥ 5 cm) and
symptomatic at the time of surgery. In two cases, surgical
repair was delayed because of a false-negative ultrasound
scan image and an unsuccessful attempt at ultrasound-
guided compression. All three patients were older than 70
years and considered a high surgical risk because of con-
current coronary or cerebrovascular disease.
A fourth case of arterial bleeding was repaired 1
month after coronary artery stenting and “successful” per-
cutaneous suturing of the femoral artery (with the Closer;
Perclose). The patient presented with fever and inguinal
pain on the 20th day after the procedure. The results of
evaluation at that time (including femoral artery ultra-
sound scan) were unremarkable, and the patient was fol-
lowed up as an outpatient. A week later, a repeat
ultrasound scan was performed for persistent symptoms; it
revealed a large femoral artery pseudoaneurysm that was
infected with Staphylococcus aureus at operation. At
surgery, the percutaneous sutures were located in the sub-
cutaneous tissue, remote from the artery.
All four arterial injuries were large, measuring about
10 mm in diameter. Three injuries involved the common
femoral artery, and one involved the proximal superficial
femoral artery. Three of the four injuries were anterior,
and one was medial. An unusual amount of severe inflam-
mation was encountered in each case, making dissection
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Fig 1. Wide exposure of femoral bifurcation to remove entrap-
ped Prostar device.
Fig 2. Posterior wall intimal injury (arrow) of common femoral
artery caused during deployment of foot portion of Closer device.
and control difficult. This increased intraoperative blood
loss, and each patient required two to four units of blood
transfusion. Direct surgical repair was accomplished in two
arteries and pledgeted repair in one. The infected
pseudoaneurysm required wide debridement of infected
artery wall and vein patch angioplasty with ipsilateral
greater saphenous vein. Pressure necrosis from large
hematomas led to significant wound breakdown in two
patients; both ultimately required a second operation for
extensive skin and soft tissue debridement with a sartorius
muscle flap for arterial coverage.
Retained device. Two devices (Prostar) required
surgical removal for entrapment after failed deployment.
The needles were trapped in the artery wall or subcuta-
neous tissue preventing device removal. Neither patient
was obese. Both devices were trapped in the common
femoral artery through an anterior entrance site (Fig 1).
Operative repair consisted of proximal and distal vascular
control through a generous longitudinal incision that
extended through the inguinal ligament. The devices
were removed through a large transverse arteriotomy,
which was then closed primarily. Some of the needles
encountered were markedly distorted and displaced in
the wound remote from the artery, in one case resulting
in an intraoperative needle stick to one member of the
operating team. Likewise, plain film radiographs were
obtained intraoperatively in both cases to ensure that all
foreign bodies had been removed. The wounds were irri-
gated liberally with antibiotic saline solution and closed
primarily. Both patients recovered without postoperative
complication.
Arterial thrombosis. Percutaneous suture closure of
the femoral artery produced acute arterial thrombosis in
two patients. The Closer device was used in both cases.
Both patients were relatively young, small women under-
going diagnostic studies with a 6F access. One patient had
limb-threatening ischemia an hour after angiography, and
the other patient had acute short-distance claudication
and foot paresthesia the following day.
At operation arteries were diminutive in size with sig-
nificant vasospasm. In both patients the common femoral
artery was approximately 1.5 cm in diameter, and the
superficial femoral artery was approximately 1 cm in diam-
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eter. One patient had the puncture site in the common
femoral artery, and one was located in the proximal super-
ficial femoral artery because of a high femoral bifurcation.
After removal of thrombus with a Fogarty catheter
(including thrombectomy of the superficial femoral and
popliteal artery in the patient with acute limb threat), a
posterior intimal dissection at the site of catheter entry was
noted (Fig 2). In both cases, a loose intimal flap from the
posterior wall was resected, and the anterior artery wall
was patched with saphenous vein. Normal pulses were
restored, and both patients had uncomplicated postopera-
tive courses. Aside from aspirin, postoperative anticoagu-
lation was not used.
DISCUSSION
The pattern of trading modest surgical morbidity asso-
ciated with traditional therapy for significant, albeit infre-
quent, surgical morbidity associated with the introduction
of new technology is common in modern medicine.
Examples include common bile duct injury with laparo-
scopic choleycystectomy12 and colon or small bowel injury
associated with percutaneous endoscopic gastrostomy.13
Proponents of new technology frequently point to device
design flaws or operator “learning curves” to explain many
of these problems.14 The surgeon, however, is inevitably
required to deal with the resultant pathology, regardless of
the cause. Therefore, it is incumbent upon surgeons to
review and share surgical experiences with complications
from these devices so that an understanding of the major
clinical and technical issues associated with new technol-
ogy can be communicated between colleagues.
Two different versions of percutaneous suturing
devices are currently approved by the Food and Drug
Administration for use: the Prostar/Techstar (Fig 3) and
more recently, the Closer (Fig 4). The Prostar (8F) and
Techstar (6F) percutaneous suture devices are composed
of a sheath containing either two or four nitinol needles
and 3-0 braided polyester suture guided by a rotating bar-
rel. The sutures are placed in the artery wall from within
the artery, and because of the diameter of the introducer,
a significant subcutaneous tunnel must be created to reach
the artery. This device has been approved for use since the
summer of 1998. The Closer device has a sheath and a
Demographics of patients with iatrogenic vascular injuries from percutaneous vascular suturing devices
Sex Age (y) Angiographer Indication Procedure Hypertension Heparin Injury
F 55 Cardiac + ETT Diagnostic coronary No No Thrombosis
F 80 Cardiac Unstable angina PTCA/stent Yes No Bleed
F 44 Interventional Liver CA Diagnostic visceral No No Thrombosis
M 75 Interventional Stroke Diagnostic cerebral Yes Yes Bleed
M 55 Cardiac Unstable angina PTCA/stent No No Retained device
F 75 Interventional Hypertension Renal PTA/stent Yes No Bleed
M 54 Cardiac Myocardial infarct PTCA/stent Yes No Retained device
M 67 Cardiac Myocardial infarct PTCA/stent Yes No Bleed/infection
CA, Cancer; ETT, exercise treadmill test; F, female; M, male; PTA, percutaneous transluminal angioplasty; PTCA, percutaneous transluminal coronary
angioplasty.
marker guide with a foot that rests on the anterior wall of
the artery to allow more accurate placement of the needles
when deployed. The needles are less deformable stainless
steel and are introduced from outside the artery. It has
been available since the autumn of 1999.
This report describes our experience with these two
different models of percutaneous suturing devices that
caused arterial injuries consisting of major arterial hemor-
rhage, retained intra-arterial device, and arterial thrombo-
sis. Although arterial hemorrhage from suture pull-
through would seem relatively simple to manage, our cases
presented a technical challenge far greater than standard
femoral pseudoaneurysm repair. This increased difficulty is
primarily due to the massive hemorrhage associated with
large defects in the artery and a severe inflammatory
response observed in these cases. Femoral pseudo-
aneurysm repair involves (1) proximal arterial control; (2)
rapid distal dissection beyond the point of injury, which is
often greatly facilitated by the expanding pseudoaneurysm
cavity; (3) distal control; and (4) repair with or without
patch grafting.3 In the current series, distal vascular con-
trol was difficult as a result of unusually extensive adhe-
sions. Each of the patients described was morbidly obese
(which contributed to the difficulty of extracorporeal knot
placement), and all had a delay in operation for various
reasons. The involved arteries were extremely friable, and
care was required to avoid injury to the arterial wall.
Arterial perforations after suture pull-through were large,
and on one occasion pledgeted repair was required. The
extent of subcutaneous bleeding and soft tissue disruption
from these large defects resulted in significant wound
complications requiring muscle flap coverage in two
patients. All of the patients had bleeding of a magnitude
to require transfusion, a finding reported by others.15
Importantly, the use of diagnostic and therapeutic ultra-
sound scan was not helpful in the treatment of these
patients. This was due to the large arterial defects encoun-
tered.
Retained devices (Prostar and Techstar) are problem-
atic because the long nitinol needles, bent at odd angles
and embedded both within the artery and surrounding tis-
sue, represent a danger to both the surgeon and the
patient. This problem has been reported previously and is
the most common adverse event associated with this
device to date.16 It appears to be related to either having
the axis of the device too perpendicular to that of the
artery or failing to align the needle sheath correctly with
the introducer, both of which result in some or all of the
emerging needles bending and missing the target. The
manufacturer has changed the design of the device
(improved guidance, stronger composition, and extra-
arterial placement of the needles) in the Closer device to
prevent this complication. However, because of potential
problems with the newer model (see later), our interven-
tional radiologists currently use the Prostar and Techstar
devices.
Extensive thrombosis requiring arterial thrombectomy
and vein patch repair was required for limb salvage in two
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Fig 3. Prostar/Techstar device for percutaneous suturing. Both
devices are of the same design and differ in French size only (6F
vs 8F). A, The barrel of device demonstrated through subcuta-
neous tissue and in contact with artery wall. The needles (small
solid arrows) are deployed from within the lumen to enter intro-
ducer device outside the wall (B). This has the potential for nee-
dle misalignment if the needle sheath is not correctly aligned with
introducer. C, Suture is pulled through device, and an extracor-
poreal knot is tied.
Fig 4. Closer device for percutaneous suturing. A, Global view
of device. Guide and angle of deployment area are rigid to help
prevent misapplication of sutures. B, Device inside arterial lumen
showing the foot deployed by moving the lever. The plunger is
used to deploy needles that traverse arterial wall. C, Closeup of
foot device deployed that helps guide needles to suture. Stainless
steel needles come from ports above and travel from outside the
artery to within. The foot device is rigid and within the artery and
can potentially damage posterior intima if artery is small and
device deployed too deep posteriorly within the vessel.
A
B
A
B
C
C
patients. These cases occurred in women with diminutive
arteries and exaggerated vasospasm. The posterior intimal
injury appeared to coincide with a site of arterial contact
from the foot portion of the Closer device, which requires
intra-arterial placement for function. This can occur if the
foot device is deployed or dragged against the posterior
artery wall, a situation usually occurring when the device
is advanced too far within the artery. Limited resection of
the intimal flap, removal of thrombus, and repair of the
artery with patch angioplasty were adequate in these cases.
Our interventional radiology group is no longer using the
Closer device, and our interventional cardiologists do not
use it in women with small arteries.
Percutaneous suturing devices are gaining wide accep-
tance by interventional radiologists and cardiologists.
With the introduction of this new technology comes a
shift in patterns of arterial injuries, which are more techni-
cally demanding than straightforward iatrogenic angio-
graphic injuries. Our anecdotal observation has been an
overall reduction in the number of femoral pseudo-
aneurysms observed after widespread use of percutaneous
suturing devices. In addition, communication with inter-
ventionalists can improve patient selection, guide the spe-
cific device used, and refine future devices.
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